Insider · CIK 0001222253

BONFIGLIO JOHN N

Reports to the SEC for 7 companies · LA JOLLA, CA

sec.gov

Transactions

Companies

Filings

CIK

0001222253

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-03-09	MRKRMarker Therapeutics, Inc.A Award	Director, President and COO	AAward	+5,220 sh	—	—	26,054
2016-12-12	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director, President and COO	MExercise/Conversion	−10.4K sh	—	—	85,416
2016-12-12	MRKRMarker Therapeutics, Inc.G Gift	Director, President and COO	GGift	+10.4K sh	—	—	10,417
2016-12-12	MRKRMarker Therapeutics, Inc.G Gift	Director, President and COO	GGift	−10.4K sh	—	—	20,834
2016-12-12	MRKRMarker Therapeutics, Inc.M Exercise/Conversion	Director, President and COO	MExercise/Conversion	+10.4K sh	$1.74	+$18.1K	31,251
2016-07-18	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and COO	AAward	+750K sh	—	—	1,150,000
2016-07-15	MRKRMarker Therapeutics, Inc.A Award	Director, President and COO	AAward	+250K sh	—	—	250,000
2015-07-23	MRKRMarker Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director, President and COO	AAward	+150K sh	—	—	400,000
2014-08-13	OGENORAGENICS INCP Purchase	Director, President and CEO	PPurchase	+1,000 sh	$1.70	+$1,704.5	385,255
2013-11-27	OGENORAGENICS INCA Award	Director, President and CEO	AAward	+175K sh	—	—	444,255
2013-11-27	OGENORAGENICS INCF Tax Payment	Director, President and CEO	FTax Payment	−60K sh	$3.00	−$180K	384,255
2013-10-18	OGENORAGENICS INCF Tax Payment	Director, President and CEO	FTax Payment	−50K sh	$2.99	−$150K	269,722
2013-10-18	OGENORAGENICS INCA Award	Director, President and CEO	AAward	+151K sh	—	—	319,722
2012-10-23	OGENORAGENICS INCF Tax Payment	Director, President and CEO	FTax Payment	−14.9K sh	$2.10	−$31.4K	168,879
2012-10-23	OGENORAGENICS INCA Award	Director, President and CEO	AAward	+56.5K sh	—	—	183,818
2012-08-06	OGENORAGENICS INCA Award	Director, President and CEO	AAward	+132K sh	—	—	162,250
2012-08-06	OGENORAGENICS INCF Tax Payment	Director, President and CEO	FTax Payment	−34.9K sh	$2.75	−$96K	127,336
2011-11-14	OGENORAGENICS INCA Award	Director, President and CEO	AAward	+29K sh	—	—	30,250
2011-09-28	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+39.2K sh	—	—	39,200
2011-08-16	OGENORAGENICS INCP Purchase	Director, President and CEO	PPurchase	+1,250 sh	$2.15	+$2,687.5	1,250
2011-05-25	OGENORAGENICS INC · Employee Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+126K sh	—	—	125,800
2010-10-20	HROWHARROW, INC.A Award	Director, President and CEO	AAward	+50K sh	$0.80	+$40K	50,000
2010-10-20	HROWHARROW, INC. · Stock option (right to buy)A Award	Director, President and CEO	AAward	+400K sh	—	—	400,000
2005-09-30	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+9,783 sh	$0.46	+$4,500.18	51,993
2005-09-02	ORCHESTRA THERAPEUTICS, INC.P Purchase	Director, CEO	PPurchase	+10K sh	$0.46	+$4,600	42,210
2005-06-30	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+6,923 sh	$0.65	+$4,499.95	32,210
2005-03-31	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+5,769 sh	$0.78	+$4,499.82	25,287
2004-12-31	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+1,980 sh	$1.61	+$3,187.8	19,518
2004-12-20	ORCHESTRA THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Director, CEO	AAward	+175K sh	—	—	250,000
2004-12-20	ORCHESTRA THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Director, CEO	AAward	+75K sh	—	—	75,000
2004-12-01	ORCHESTRA THERAPEUTICS, INC.Non-Qualified Stock Option (right to buy)A Award	Director, CEO	AAward	+75K sh	—	—	75,000
2004-09-30	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+2,656 sh	$1.20	+$3,187.2	17,538
2004-08-10	ORCHESTRA THERAPEUTICS, INC.A Award	Director, CEO	AAward	+5,000 sh	$0.66	+$3,300	14,882
2004-08-10	ORCHESTRA THERAPEUTICS, INC.P Purchase	Director, CEO	PPurchase	+5,000 sh	$0.66	+$3,300	14,882
2004-01-19	ORCHESTRA THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Director, CEO	AAward	+25K sh	—	—	25,000
2003-12-19	ORCHESTRA THERAPEUTICS, INC.Incentive Stock Option (right to buy)A Award	Director, CEO	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Mar 134
TAPIMMUNE INC0001144204-17-014231
SEC(opens sec.gov)
Dec 144
TAPIMMUNE INC0001144204-16-139495
SEC(opens sec.gov)
Jul 194
TAPIMMUNE INC0000899243-16-025288
SEC(opens sec.gov)
Nov 94
TAPIMMUNE INC0000899243-15-007780
SEC(opens sec.gov)
Aug 134
ORAGENICS INC0001209191-14-052124
SEC(opens sec.gov)
Dec 24
ORAGENICS INC0001209191-13-054670
SEC(opens sec.gov)
Oct 224
ORAGENICS INC0001181431-13-054782
SEC(opens sec.gov)
Oct 254
ORAGENICS INC0001181431-12-055509
SEC(opens sec.gov)
Aug 84
ORAGENICS INC0001181431-12-044345
SEC(opens sec.gov)
Nov 164
ORAGENICS INC0001181431-11-056516
SEC(opens sec.gov)
Sep 304
ORAGENICS INC0001181431-11-050847
SEC(opens sec.gov)
Aug 164
ORAGENICS INC0001181431-11-045747
SEC(opens sec.gov)

Companies

Address

4275 EXECUTIVE SQUARE, SUITE 230

LA JOLLA, CA, 92037